NEW YORK (Reuters Health) - Most women expect hot flashes as a part of the "change of life," but more than half start sweating before menopause has actually begun, according to a survey.
BRUSSELS (Reuters) - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of 146 million euros ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such deals.
LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals.
CHICAGO (Reuters) - Shares of U.S. hospital operators have been on a tear this year, on average posting triple the gains of the broader stock market, as investors tallied up the benefits of President Barack Obama's healthcare reform.
CHICAGO (Reuters) - A swine virus deadly to young pigs, one never before seen in North America, is spreading rapidly across the United States and proving harder to control than previously believed.
LONDON (Reuters) - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.
WASHINGTON (Reuters) - Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up millions of uninsured Americans for health coverage in the coming months.
(Reuters) - The U.S. Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co.'s long-acting treatment for schizophrenia, Zyprexa Relprevv.
NEW YORK (Reuters Health) - If a person doesn't have much success with one pain treatment, they may say the next one they try doesn't work so great either, suggests a new study from Germany.
LITTLETON, New Hampshire (Reuters) - New Hampshire is set to become the final state in New England to allow medical marijuana after negotiators from the Republican-controlled Senate and Democratic-controlled House agreed Tuesday on a bill backed by Governor Maggie Hassan.
(Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invalid, paving the way for introduction of a generic version of the medicine, the Danish drugmaker said on Tuesday.
NEW YORK (Reuters Health) - Large independent doctor practices that focus on primary care tend to spend less money and are more likely to meet guidelines for Americans on Medicare than smaller groups, according to a new study.
NEW YORK (Reuters Health) - Some people who received potentially contaminated steroid injections may benefit from a MRI to check for signs of infection, a new study suggests - even if they don't have obvious symptoms.
NEW YORK (Reuters Health) - Studies that are funded by pharmaceutical companies or involve industry-backed scientists tend to be more prominent at cancer meetings than independent studies, a new report suggests.
(Reuters) - The Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co's long-acting treatment for schizophrenia, Zyprexa Relprevv.
LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on Tuesday.
LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, along with a related French factory, to Aspen Pharmacare in a deal that could be worth some $1 billion.
LONDON (Reuters) - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity by using cheap social media channels to promote fat-, salt- and sugar-laden foods, the World Health Organisation's Europe office said on Tuesday.
LONDON (Reuters) - AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to the world-renowned Addenbrooke's Hospital, for its new $500 million global headquarters and research center.
(Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand.
(Reuters) - Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works as well as traditional bone grafts taken from patients, but it may not be as safe.
NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending them to surgery or radiation right away, according to a new study.
DUBAI (Reuters) - Four more people have died and three more have fallen ill in Saudi Arabia from the new SARS-like coronavirus MERS-CoV, the Saudi Health Ministry said on Monday.
LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, according to a World Health Organisation-led team of researchers.
PHOENIX (Reuters) - Arizona's Republican Governor Jan Brewer signed a law on Monday to expand Medicaid, embracing a key part of Democratic President Barack Obama's healthcare plan in a hard-won policy victory over conservatives in her own party.
NEW YORK (Reuters Health) - Increasing the number of hamburgers and other red meat people eat on a daily basis is linked to a higher risk of developing diabetes down the road, according to a new study.
NEW YORK (Reuters Health) - Ouch: Boys know that toilet seats are an occupational hazard of potty training, but a new study suggests the number of genital injuries caused by falling toilet toppers is growing.
WILMINGTON, Delaware (Reuters) - A jury on Monday cleared a doctor of negligence in a lawsuit filed by a Delaware truck driver who underwent a penile implant procedure and ended up with an erection that lasted eight months.
WASHINGTON (Reuters) - The Supreme Court ruled on Monday regulators can challenge deals between brand-name drug companies and generic rivals that delay cheaper medicines from going on sale, which regulators say increase costs to consumers by billions of dollars.
NEW YORK (Reuters) - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter.